Id Counterfeit Pharmaceuticals with Portable Raman
Rigaku
| « Previous month | Next month » |
22-Dec-2006
GE Healthcare scraps arrays
22-Dec-2006 - GE will drop the CodeLink array system in 2007 and close a US-based production facility.
Thermo acquires Cohesive
22-Dec-2006 - Thermo Fisher Scientific has bought Cohesive, an advanced sample extraction and liquid chromatography products manufacturer.
New e-learning tool to train lab analysts
22-Dec-2006 - Analytical laboratory LGC has set up an initiative to develop a new approach to training for analysts working in molecular laboratories, with a novel e-learning tool.
UK gov't lends support to ultrasound spectroscopy R&D
22-Dec-2006 - The UK's Department of Trade and Industry (DTI) has pledged its support to an ultrasound spectroscopy project conducted by LGC, to evaluate its potential as a Process Analytical Tool (PAT)...
20-Dec-2006
Monoclonal T cell receptors to be used for vaccine validation
20-Dec-2006 - German biotech company MediGene and Sanofi Pasteur have signed a deal to develop new monoclonal T cell receptors that the vaccine maker will use to develop and validate vaccines more...
Injectable antipsychotic drug delivered by Captisol technology
20-Dec-2006 - Specialty pharmaceutical company CyDex has been boosted by the news that an intramuscular injection formulation of schizophrenia drug Abilify, which makes use of its Captisol solubility technology has been launched...
NNE scoops up Fresenius' Pharmaplan
20-Dec-2006 - NNE and Fresenius ProServe yesterday announced they had reached an agreement by which NNE will acquire Fresenius' subsidiary, engineering company Pharmaplan GmbH.
Wyeth kicks off CMO agreement with Crucell
20-Dec-2006 - Crucell yesterday announced it had received the first orders from US-headquartered Wyeth Biotech. The order represents the first move following the finalisation of the contract manufacturing agreement between the two...
More speculation on inhaled insulin market potential
20-Dec-2006 - Innovative, non-invasive new ways of delivering insulin are poised to transform diabetes management, despite concerns about their safety and efficacy, according to new research.
19-Dec-2006
Medichem passes third consecutive FDA plant inspection
19-Dec-2006 - Pharma company Medichem has announced it has passed a US Food and Drug Administration (FDA) inspection without any problem for the third consecutive time.
Adenovirus patent awarded to Introgen
19-Dec-2006 - Introgen Therapeutics last week announced that it has been granted a European patent for the commercial production of adenoviral compositions.
Nanoparticles to treat drug overdoses
19-Dec-2006 - Researchers have discovered that using nanotechnology could help reduce fatalities from drug overdoses, as nanoparticles can act as potential antidotes.
Fertin develops battle ready antimicrobial chewing gum
19-Dec-2006 - Medicated chewing gum company Fertin Pharma has announced a collaboration with the US Army Dental Research and Trauma Detachment (USADRT) on the first antimicrobial chewing gum to lower incidences of...
Imaging tech to thwart pill pirates
19-Dec-2006 - A UK based firm aims to take up the fight against drug counterfeiters with its innovative imaging and spectroscopy products. TeraView says its technology could aid regulators and law enforcement...
18-Dec-2006
Solvay deal suggests Novasep's strategy has paid off
18-Dec-2006 - Solvay has contracted Novasep to provide synthesis of two active pharmaceutical ingredients, following Novasep's decision to combine synthesis and processing expertise.
Evolving enzymes - increasing efficiency for drug makers
18-Dec-2006 - The directed evolution of enzymes can lead to more efficient tools for the synthesis of drug molecules.
Patheon limps in with end of year results
18-Dec-2006 - Patheon last week announced its fourth quarter and end of year financial results after a tough year for the contract drug manufacturer.
EU chemical law passed amid controversy
18-Dec-2006 - EU lawmakers have approved a new chemical law aimed at making producers and importers of chemicals, used in goods such as personal care products, prove that the substances they put...
Dr Reddy's increases its manufacturing capacity
18-Dec-2006 - Dr Reddy's Laboratories has boosted its ability to serve Western pharmaceutical markets with an increase in its manufacturing capacity for drug formulations.
Shire to get European approval for its ulcerative colitis drug
18-Dec-2006 - Pharma company Shire has agreed with European regulators on labelling information for its ulcerative colitis drug Mezavant, a further step in the firm's ambition to capture more of the $1.6bn...
MonoSolRx's thin film drug delivery system attracts investors
18-Dec-2006 - Drug delivery company MonoSolRx has announced it has received a $38m (€29m) funding from an investment group, illustrating the appeal of the company's dissolving film technology.
15-Dec-2006
GreeneChip for faster disease diagnosis
15-Dec-2006 - New technology provides unprecedented opportunities for unbiased pathogen discovery.
The changing face of allergy therapeutics
15-Dec-2006 - Oral immuno-therapies offer a cure, rather than just relief, to millions of hayfever sufferers worldwide.
AQIX liquid preserves tissue life and function
15-Dec-2006 - Synthetic extra-cellular fluid maintains cell function and life while increasing pre-clinical trial reproducibility.
14-Dec-2006
J&J's drug-eluting stents survive FDA scrutiny
14-Dec-2006 - The US Food and Drug Administration (FDA) has decided against restricting the use of drug-eluting cardiac stents after a two-day investigation into their potential to increase blood clots.
Dr Reddy's overcomes formulation challenge to develop 4-in-1 heart pill
14-Dec-2006 - Dr Reddy's Laboratories has started first clinical trials of a "four-in-one" polypill clinical trial, which could revolutionise the cardiovascular drugs market.
Ben Venue wins Vion anti-cancer contract
14-Dec-2006 - Vion Pharmaceuticals has awarded a manufacturing agreement with Ohio based contract manufacturers Ben Venue Laboratories to produce its lead anticancer drug, Cloretazine (VNP40101M).
Schott's pharma packaging business keeps growing
14-Dec-2006 - Schott has reported a 15 per cent growth rate for its pharma packaging business, three times higher than the growth of the overall pharma industry.
13-Dec-2006
Solvay reinforces outsourcing relationship with Lonza
13-Dec-2006 - Lonza Group and Solvay Pharmaceuticals have today announced a strategic long-term manufacturing alliance.
Roche invests in new 'molecular machete' drug delivery enhancer
13-Dec-2006 - Roche has invested $20m in a new technology that has the potential to dramatically enhance the delivery of subcutaneous drugs by acting like a 'molecular machete'.
Schwarz awards contract for new Irish API manufacturing facility
13-Dec-2006 - Schwarz Pharma has awarded an engineering and procurement contract to a Jacobs Engineering Group subsidiary for the development of a new active pharmaceutical ingredient (API) manufacturing facility in Ireland.
AstraZeneca opens first manufacturing plant in the Middle East
13-Dec-2006 - Pharmaceutical giant AstraZeneca has invested in a tablet manufacturing plant in Egypt, which could form a launching pad for an expansion into emerging markets.
12-Dec-2006
Singapore eyes biologics manufacturing
12-Dec-2006 - Biologic drug manufacturing is slowly starting to take off in Singapore and is expected to be a key component of the country's drug manufacturing activity in the future.
Gamma-radiation resistant RFID chip GammaTag debuts
12-Dec-2006 - The first radio frequency identification (RFID) tag that can resist gamma irradiation has been developed to track pharmaceutical products early on and throughout the supply chain.
More jobs cuts at BASF as Asian API market closes in
12-Dec-2006 - Almost 130 jobs will be lost at BASF's Minden site as the company succumbs to growing pressure from the Asian generic active pharmaceutical ingredient (API) market.
Delivery technology 'could speed up siRNA development'
12-Dec-2006 - US researchers have developed a novel delivery vehicle for siRNA, an up-and-coming technology for switching off genes in the body that could accelerate its use in drug development.
Glass research opens new window for drug delivery
12-Dec-2006 - A new 'glass' making technique that improves stability and durability could lead to novel coatings and improvements in drug delivery, according to researchers at the University of Wisconsin-Madison and the...
11-Dec-2006
Auxilium halts drug trials to look into manufacturing issue
11-Dec-2006 - Biotech drugmaker Auxilium has temporarily suspended Phase III clinical trials to investigate a manufacturing problem with its new injectable enzyme batch, which could potentially cost the firm $1m (€750,000).
Oracle bolsters pharma packaging
11-Dec-2006 - Oracle has bought US firm Tolas Healthcare Packaging in a bid to bolster its pharma packaging capabilities.
Siegfried signs over capacity to Celgene in €34.9m deal
11-Dec-2006 - Fine chemicals maker Siegfried Holdings has agreed to sign over part of the production capacity of its Zofingen production plant to US biotech Celgene Corp in a collaboration worth €34.9m.
US Senate approves FDA chief nomination
11-Dec-2006 - The US Senate has confirmed Andrew von Eschenbach as the official Commissioner of the Food and Drug Administration (FDA) after months of delay due to complaints about the regulator's oversight.
Novel ionic liquid method promises low-cost levodopa production
11-Dec-2006 - Dutch researchers have developed a new way of making a Parkinson's disease drug using an inexpensive ionic liquid method that could yield cost savings of €11.3 million per annum.
08-Dec-2006
PerkinElmer buys Evotec Technologies
08-Dec-2006 - PerkinElmer strengthens its position in the cell analysis instrumentation market by acquiring Evotec Technologies for approximately €23m.
07-Dec-2006
Baxter expands lyophilisation capacity
07-Dec-2006 - Baxter is expanding its lyophilisation capacity at its German facility to support future growth of its contract manufacturing business for anti-cancer drugs.
Genzyme expands manufacturing capacity in Europe
07-Dec-2006 - US biotechnology company Genzyme invests heavily in Lyon, boosting their biotech-production operations in Europe
Panacea takes stake in Cambridge's new vaccine biz
07-Dec-2006 - Indian pharma firm Panacea Biotec has taken a 10 percent stake in UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m (€1.4m) under a new joint venture deal signed between the...
Phoqus joins forces with GSK on oral drug delivery system, Qtrol
07-Dec-2006 - Phoqus pharmaceuticals reaches milestone in GSK deal on Qtrol, due to an increasing demand for drug delivery system.
Alcan splashes out on new packaging centre
07-Dec-2006 - Packaging maker Alcan has announced it will invest $27.5m (€20.7m) for an expansion project in its US pharma centre to meet the growing demand for pharmaceutical flexible packaging materials.
06-Dec-2006
Nastech delays osteoporosis nasal spray development
06-Dec-2006 - Nastech missed out on a $15m (€11m) milestone payment after having to delay the development of its new nasal spray for the treatment of osteoporosis because of the need of...
Flow reactor heater for high-speed flow chemistry
06-Dec-2006 - New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.
Auxilium slices contract manufacturing deal with Cobra
06-Dec-2006 - Biotech company Auxilium has decided to amend its manufacturing agreement with UK-based Cobra biologics in order to favour the in-house production of its new injectable enzyme.
Compromise agreed on REACH, a new EU chemical law
06-Dec-2006 - A late night compromise on controversial EU legislation on chemical control - REACH - means it could now come into play as planned in 2007.
ProMetic and Novartis team up for new vaccine purification technology
06-Dec-2006 - The UK subsidiary of ProMetic Life Sciences has signed a deal with Novartis to develop a new purification technology for recombinant protein vaccines that is claimed to be more efficient...
05-Dec-2006
Lonza and BioOne continue investing in Singapore
05-Dec-2006 - Swiss custom manufacturer Lonza and Singapore's BioOne Capital have announced a new joint venture to build a $350m (€263m) large-scale manufacturing facility in Singapore.
Millipore's single-use container film enters the bioprocessing market
05-Dec-2006 - Millipore has introduced a new container film - PureFlex - that ties in with the trend towards increasing use of disposable products within the bioprocessing sector.
Biolex technology produces superior MAbs
05-Dec-2006 - A new cell culture process developed by Biolex Pharmaceuticals produces monoclonal antibodies which are both more potent and more effective.
AAIPharma to offer 'one-stop shop' for drug development
05-Dec-2006 - AAIPharma has announced it has signed a contract manufacturing agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims to provide a "one-stop drug development solution" for drug makers.
Pfizer manufacturing plant in question after torcetrapib blow
05-Dec-2006 - A hefty investment by Pfizer in an Irish manufacturing facility could prove to be a waste after the potential blockbuster it was designed to make has been canned.
04-Dec-2006
Rockwood sheds Groupe Novasep in €425m deal
04-Dec-2006 - Rockwood Holdings announced last week that it has reached an agreement to sell its subsidiary Groupe Novasep to a consortium of buyers in a transaction valued at €425m.
Demand for high visibility packaging on the rise
04-Dec-2006 - A US research company has published a report placing clamshell style packaging as the forerunner in the burgeoning high visibility packaging industry, with blister packs also on the increase.
Flu vaccine capacity at its highest… for now
04-Dec-2006 - Pharmaceutical giants push their flu vaccine production capacity to the limit but will it have an effect on future supply?
Bioxel reaches Europe with taxane-based drug
04-Dec-2006 - Canadian pharma manufacturer Bioxel has announced it has received several orders for its paclitaxel product - a taxane-based drug effective to treat cancer - from two European customers representing a...
Cardinal divests drug manufacturing unit
04-Dec-2006 - Cardinal Health, the leading contract manufacturer for the pharmaceutical industry, has announced its plans to sell its drug manufacturing and packaging unit in order to focus on its health-care business.
| « Previous month | Next month » |
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
